Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Authors:
  • FMFaisal S. Minhaj
    Faisal S. Minhaj
  • RCRosalind J. Carter
    Rosalind J. Carter
  • JDJonathan Duffy
    Jonathan Duffy
  • PSPanayampalli S. Satheshkumar
    Panayampalli S. Satheshkumar
  • KDKevin P. Delaney
    Kevin P. Delaney
  • LQLaura A. S. Quilter
    Laura A. S. Quilter
  • RKRachel E. Kachur
    Rachel E. Kachur
  • CMCatherine McLean
    Catherine McLean
  • DMDanielle L. Moulia
    Danielle L. Moulia
  • DKDavid T. Kuhar
    David T. Kuhar
  • MPMarie A. de Perio
    Marie A. de Perio

Abstract
This report describes ACIP’s 2023 recommendation for JYNNEOS vaccine use in people 18 years and older who are at risk for mpox during an mpox outbreak.

This publication has 21 references indexed in Scilit: